Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Sinbobon Apr 09, 2013 11:54am
191 Views
Post# 21231409

Price firming around $1.07 ish

Price firming around $1.07 ish

In my opinion buyers here will be rewarded. I just did.

 

Talk about nervous markets!!! Trigger fingers and traders are very active for this stock today... and no doubt those that gamble have and will make a profit on the swings. My buy was at $1.07.

 

My guess is that BTI has signalled to Roche that it will happily proceed on it's own. My impression is that Roche is playing hardball and thinks time is on it's side. They can always up the ante if a competitor comes along I suppose. Roche's small molecular, narrow taget 'shuttle' can not compare at all to Transcend.

 

Someone could get caught offside here. As pmrider alluded to, the stakes are too big for some pharma not to take the leap of faith with Transcend. Roche's game has nothing to do with Abbott, Shire, UCB  or others.

 

Almost every day there is bad news coming out of R&D and clinical trials re new drug entities. Transcend is not a new drug entity in iitself.

 

Good trading everyone. I am pleased to have purchased at $1.07.

 

Bullboard Posts